$0.58
-0.01 (-1.69%)
Open$0.61
Previous Close$0.59
Day High$0.61
Day Low$0.58
52W High$15.00
52W Low$0.56
Volume—
Avg Volume55.6K
Market Cap100.84M
P/E Ratio—
EPS$-0.17
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 44.46M | 45.50M | 43.44M |
| Net Income | 5.47M | 5.03M | 5.89M |
| Profit Margin | 12.3% | 11.1% | 13.6% |
| EBITDA | 8.24M | 9.46M | 8.95M |
| Free Cash Flow | 4.73M | 3.67M | 4.46M |
| Rev Growth | +4.4% | +9.5% | -0.1% |
| Debt/Equity | 0.49 | 0.48 | 0.41 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |